Morabeza Health Center Llc in Central Falls, RI - Case Management

Morabeza Health Center Llc is a mental health clinic (Case Management) in Central Falls, Rhode Island. The current practice location for Morabeza Health Center Llc is 555 Broad St, Central Falls, Rhode Island. For appointments, you can reach them via phone at (401) 771-2782. The mailing address for Morabeza Health Center Llc is 555 Broad St, Central Falls, Rhode Island and phone number is (401) 771-2782.

Morabeza Health Center Llc is licensed to practice in * (Not Available) (license number ) and its NPI number is 1306526355. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (401) 771-2782.

Contact Information

	Morabeza Health Center Llc
	555 Broad St Central Falls RI 02863-2836
	(401) 771-2782
	Not Available

Mental Health Clinic Profile

Full Name	Morabeza Health Center Llc
Speciality	Case Management
Location	555 Broad St, Central Falls, Rhode Island
Authorized Official Name and Position	Bianca Gerena (ADMIN)
Authorized Official Contact	5615024720
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Morabeza Health Center Llc 555 Broad St Central Falls RI 02863-2836 Ph: (401) 771-2782	Morabeza Health Center Llc 555 Broad St Central Falls RI 02863-2836 Ph: (401) 771-2782

NPI Details:

NPI Number	1306526355
Provider Enumeration Date	07/24/2023
Last Update Date	10/25/2023
Certification Date	10/25/2023

Medical Identifiers

Medical identifiers for Morabeza Health Center Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1306526355	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	(* (Not Available))	Secondary
251B00000X	Case Management	(* (Not Available))	Primary

News Archive

PCI after lung cancer treatment reduces risk of brain metastases in stage III NSCLC patients

Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Data reveals higher autism prevalence in CDC's ADDM Network

One in 44 (2.3%) 8-year-old children have been identified with autism spectrum disorder according to an analysis of 2018 data published today in CDC's Morbidity and Mortality Weekly Report (MMWR) Surveillance Summaries.

Study: Child and adolescent health improved but maternal mortality worsened in the U.S.

The United States is one of only eight countries in the world where decreases in child and adolescent mortality over a 27-year period haven't also been matched by reductions in maternal mortality, according to a new scientific study.

Researchers receive $540M from Ludwig Cancer Research to accelerate research on metastasis

Cancer researchers at the University of Chicago and five other leading institutions will share equally in a $540 million gift from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig. Ludwig Cancer Research is an international community of researchers dedicated to pursuing life-changing discoveries to alter the course of cancer.

Promising compound blocks production of beta amyloid peptides in Alzheimer's mouse model

Offering a potential early intervention for Alzheimer's disease (AD), researchers at University of California, San Diego School of Medicine and Cenna Biosciences, Inc. have identified compounds that block the production of beta amyloid peptides in mice.

Morabeza Health Center Llc - Mental Health Clinic in Central Falls, RI